US Stock MarketDetailed Quotes

IGC IGC Pharma

Watchlist

0.4860
+0.0468+10.66%

Close Apr 16 16:00 ET

0.5109
+0.0249+5.12%

Post 17:52 ET

32.11MMarket Cap-1869P/E (TTM)

IGC Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Dec 31, 2023

(Q2)Sep 30, 2023

(Q1)Jun 30, 2023

(FY)Mar 31, 2023

(Q4)Mar 31, 2023

(Q3)Dec 31, 2022

(Q2)Sep 30, 2022

(Q1)Jun 30, 2022

(FY)Mar 31, 2022

(Q4)Mar 31, 2022

Total revenue

-38.55%204K

44.06%291K

161.79%555K

129.47%911K

36.07%166K

133.80%332K

260.71%202K

175.32%212K

-55.79%397K

50.62%122K

Operating revenue

-38.55%204K

44.06%291K

161.79%555K

129.47%911K

36.07%166K

133.80%332K

260.71%202K

175.32%212K

-55.79%397K

50.62%122K

Cost of revenue

-69.13%71K

74.63%117K

328.57%300K

131.03%469K

90.74%103K

187.50%230K

272.22%67K

37.25%70K

-74.14%203K

0.00%54K

Gross profit

30.39%133K

28.89%174K

79.58%255K

127.84%442K

-7.35%63K

64.52%102K

255.26%135K

446.15%142K

71.68%194K

151.85%68K

Operating expense

31.55%3.13M

1.60%2.67M

-18.68%2.39M

-23.10%12.01M

-37.56%4.1M

-2.74%2.38M

-40.20%2.62M

32.61%2.94M

76.78%15.62M

133.11%6.57M

Selling and administrative expenses

41.55%2.23M

-24.69%1.4M

6.26%1.65M

-35.66%8.55M

-32.37%3.61M

-23.96%1.57M

-54.87%1.86M

-12.73%1.55M

68.08%13.29M

114.81%5.34M

Research and development costs

12.03%903K

65.10%1.27M

-46.41%747K

48.54%3.46M

-60.02%493K

113.79%806K

178.26%768K

213.96%1.39M

150.81%2.33M

269.16%1.23M

Operating profit

-31.61%-3M

-0.12%-2.49M

23.66%-2.14M

25.00%-11.57M

37.87%-4.04M

4.49%-2.28M

42.78%-2.49M

-27.71%-2.8M

-76.85%-15.43M

-132.93%-6.5M

Net non-operating interest income expense

Other net income (expense)

-9,034.48%-2.59M

-13.04%40K

276.47%64K

-84.22%65K

550.00%9K

625.00%29K

1,050.00%46K

-95.81%17K

573.56%412K

98.73%-2K

Special income (charges)

---2.62M

----

--0

----

71.01%-49K

92.90%-12K

-Less:Impairment of capital assets

--2.62M

----

--0

----

-Write off

----

--0

----

-71.01%49K

-92.90%12K

Other non- operating income (expenses)

10.34%32K

-13.04%40K

276.47%64K

-85.90%65K

-10.00%9K

625.00%29K

1,050.00%46K

-96.16%17K

462.20%461K

-9.09%10K

Income before tax

-148.51%-5.59M

-0.37%-2.45M

25.49%-2.08M

23.38%-11.51M

38.03%-4.03M

5.54%-2.25M

43.78%-2.44M

-55.76%-2.79M

-70.42%-15.02M

-120.52%-6.5M

Income tax

Net income

-148.51%-5.59M

-0.37%-2.45M

25.49%-2.08M

23.38%-11.51M

38.03%-4.03M

5.54%-2.25M

43.78%-2.44M

-55.76%-2.79M

-70.42%-15.02M

-120.52%-6.5M

Net income continuous Operations

-148.51%-5.59M

-0.37%-2.45M

25.49%-2.08M

23.38%-11.51M

38.03%-4.03M

5.54%-2.25M

43.78%-2.44M

-55.76%-2.79M

-70.42%-15.02M

-120.52%-6.5M

Minority interest income

Net income attributable to the parent company

-148.51%-5.59M

-0.37%-2.45M

25.49%-2.08M

23.38%-11.51M

38.03%-4.03M

5.54%-2.25M

43.78%-2.44M

-55.76%-2.79M

-70.42%-15.02M

-120.52%-6.5M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-148.51%-5.59M

-0.37%-2.45M

25.49%-2.08M

23.38%-11.51M

38.03%-4.03M

5.54%-2.25M

43.78%-2.44M

-55.76%-2.79M

-70.42%-15.02M

-120.52%-6.5M

Basic earnings per share

-125.00%-0.09

0.00%-0.05

20.00%-0.04

26.67%-0.22

33.33%-0.08

20.00%-0.04

44.44%-0.05

-25.00%-0.05

-42.86%-0.3

-71.43%-0.12

Diluted earnings per share

-125.00%-0.09

0.00%-0.05

20.00%-0.04

26.67%-0.22

33.33%-0.08

20.00%-0.04

44.44%-0.05

-25.00%-0.05

-42.86%-0.3

-71.43%-0.12

Dividend per share

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(Q3)Dec 31, 2023	(Q2)Sep 30, 2023	(Q1)Jun 30, 2023	(FY)Mar 31, 2023	(Q4)Mar 31, 2023	(Q3)Dec 31, 2022	(Q2)Sep 30, 2022	(Q1)Jun 30, 2022	(FY)Mar 31, 2022	(Q4)Mar 31, 2022
Total revenue	-38.55%204K	44.06%291K	161.79%555K	129.47%911K	36.07%166K	133.80%332K	260.71%202K	175.32%212K	-55.79%397K	50.62%122K
Operating revenue	-38.55%204K	44.06%291K	161.79%555K	129.47%911K	36.07%166K	133.80%332K	260.71%202K	175.32%212K	-55.79%397K	50.62%122K
Cost of revenue	-69.13%71K	74.63%117K	328.57%300K	131.03%469K	90.74%103K	187.50%230K	272.22%67K	37.25%70K	-74.14%203K	0.00%54K
Gross profit	30.39%133K	28.89%174K	79.58%255K	127.84%442K	-7.35%63K	64.52%102K	255.26%135K	446.15%142K	71.68%194K	151.85%68K
Operating expense	31.55%3.13M	1.60%2.67M	-18.68%2.39M	-23.10%12.01M	-37.56%4.1M	-2.74%2.38M	-40.20%2.62M	32.61%2.94M	76.78%15.62M	133.11%6.57M
Selling and administrative expenses	41.55%2.23M	-24.69%1.4M	6.26%1.65M	-35.66%8.55M	-32.37%3.61M	-23.96%1.57M	-54.87%1.86M	-12.73%1.55M	68.08%13.29M	114.81%5.34M
Research and development costs	12.03%903K	65.10%1.27M	-46.41%747K	48.54%3.46M	-60.02%493K	113.79%806K	178.26%768K	213.96%1.39M	150.81%2.33M	269.16%1.23M
Operating profit	-31.61%-3M	-0.12%-2.49M	23.66%-2.14M	25.00%-11.57M	37.87%-4.04M	4.49%-2.28M	42.78%-2.49M	-27.71%-2.8M	-76.85%-15.43M	-132.93%-6.5M
Net non-operating interest income expense
Other net income (expense)	-9,034.48%-2.59M	-13.04%40K	276.47%64K	-84.22%65K	550.00%9K	625.00%29K	1,050.00%46K	-95.81%17K	573.56%412K	98.73%-2K
Special income (charges)	---2.62M	----	----	--0	--0	--0	----	----	71.01%-49K	92.90%-12K
-Less:Impairment of capital assets	--2.62M	----	----	----	----	--0	----	----	----	----
-Write off	----	----	----	--0	----	----	----	----	-71.01%49K	-92.90%12K
Other non- operating income (expenses)	10.34%32K	-13.04%40K	276.47%64K	-85.90%65K	-10.00%9K	625.00%29K	1,050.00%46K	-96.16%17K	462.20%461K	-9.09%10K
Income before tax	-148.51%-5.59M	-0.37%-2.45M	25.49%-2.08M	23.38%-11.51M	38.03%-4.03M	5.54%-2.25M	43.78%-2.44M	-55.76%-2.79M	-70.42%-15.02M	-120.52%-6.5M
Income tax	0	0	0	0	0	0	0	0	0	0
Net income	-148.51%-5.59M	-0.37%-2.45M	25.49%-2.08M	23.38%-11.51M	38.03%-4.03M	5.54%-2.25M	43.78%-2.44M	-55.76%-2.79M	-70.42%-15.02M	-120.52%-6.5M
Net income continuous Operations	-148.51%-5.59M	-0.37%-2.45M	25.49%-2.08M	23.38%-11.51M	38.03%-4.03M	5.54%-2.25M	43.78%-2.44M	-55.76%-2.79M	-70.42%-15.02M	-120.52%-6.5M
Minority interest income
Net income attributable to the parent company	-148.51%-5.59M	-0.37%-2.45M	25.49%-2.08M	23.38%-11.51M	38.03%-4.03M	5.54%-2.25M	43.78%-2.44M	-55.76%-2.79M	-70.42%-15.02M	-120.52%-6.5M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-148.51%-5.59M	-0.37%-2.45M	25.49%-2.08M	23.38%-11.51M	38.03%-4.03M	5.54%-2.25M	43.78%-2.44M	-55.76%-2.79M	-70.42%-15.02M	-120.52%-6.5M
Basic earnings per share	-125.00%-0.09	0.00%-0.05	20.00%-0.04	26.67%-0.22	33.33%-0.08	20.00%-0.04	44.44%-0.05	-25.00%-0.05	-42.86%-0.3	-71.43%-0.12
Diluted earnings per share	-125.00%-0.09	0.00%-0.05	20.00%-0.04	26.67%-0.22	33.33%-0.08	20.00%-0.04	44.44%-0.05	-25.00%-0.05	-42.86%-0.3	-71.43%-0.12
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall